With only one month left until the 5th LNP Formulation and Process Development Summit begins in Boston, SyVento BioTech is preparing to join this leading global forum focused on advancing lipid nanoparticle science. Taking place from 6 April to 8 April 2026, the summit will bring together experts driving innovation in LNP formulation, analytical development and scalable manufacturing solutions.
Our team continues to advance high performance LNP solutions that enable precise delivery, enhanced stability and efficient scale up for next generation mRNA-based therapeutics. Through our proprietary LNP platforms and comprehensive development and GMP manufacturing capabilities, we support partners aiming to translate scientific innovation into clinical impact.
SyVento BioTech will be represented by Sujit Jain, Commercial Advisor, who will be available to discuss current challenges and emerging opportunities in LNP design, development and manufacturing.
